Skip to main content

ST Pharm

ST Pharm Co Ltd is a South Korean contract development and manufacturing organization specializing in nucleic acid therapeutics and active pharmaceutical ingredients. The company manufactures oligonucleotide building blocks, mRNA capping materials, small molecule APIs, and generic chemical pharmaceuticals. Main revenue drivers consist of CDMO contract manufacturing fees for clinical-stage oligonucleotides and commercial sales of active pharmaceutical ingredients. ST Pharm serves global biopharmaceutical enterprises, biotechnology innovators, and generic drug companies across North America, Europe, and Asia. The company holds a world-leading CDMO market position in large-scale monomer and oligonucleotide synthesis for RNA therapies. Headquartered in Seoul, South Korea, ST Pharm Co Ltd is listed on the KOSDAQ market.

3 of the funds FundTelligence covers report a position in ST Pharm.

Sector
Health Care
Country
South Korea
Funds holding it
3

Funds holding ST Pharm

Loading...